Similar to this, HSCT does not ameliorate IBD despite correcting the immune defect in patients with IKBKG deficiency, suggesting that it is the epithelial deficiency of NEMO, and not the hematopoietic cells deficiency that leads to intestinal inflammation (74). Here, IKBKG is linked to inflammatory bowel disease.